Roche gets RoActemra Europe OK for children with RA – Pharma Times

August 4, 2011 by  
Filed under Osteo-Arthritis News

Roche gets RoActemra Europe OK for children with RA
Pharma Times
Roche has garnered another approval in Europe for its biologic RoActemra, this time for systemic juvenile idiopathic arthritis. Specifically, the European Commission has approved the use of RoActemra (tocilizumab) for the treatment of active sJIA in

and more »

More Info: Click here

“Finally, you can have the same Revolutionary Yoga Program top athletes use for TOTAL mind-body fitness ... in just 30 minutes a day!”

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

This blog is kept spam free by WP-SpamFree.

Access denied for user ''@'localhost' (using password: NO)